Explore how authorized biologic alternatives, or biosimilars, compare to authorized generics. Learn about FDA approval, cost savings, and interchangeability.
Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs. The FDA requires identical active ingredients, bioequivalence testing, and strict manufacturing controls. Over 90% of U.S. prescriptions are generics, saving $373 billion annually.